Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Annals of Internal Medicine

• Publication date

  2015-09-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.7326/M14-2470PMID 26258401
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Estimating the Occurrence of Renal Complications Among Persons With Ankylosing Spondylitis

  2014cited by this paper
• Validation of international algorithms to identify adults with inflammatory bowel disease in health administrative data from Ontario, Canada.

  2014influential reference
• Ankylosing spondylitis and other inflammatory spondyloarthritis increase the risk of developing type 2 diabetes in an Asian population

  2014cited by this paper
• Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Part of a Common Spectrum or Distinct Diseases?

  2013cited by this paper
• Differences Between Women and Men With Recent‐Onset Axial Spondyloarthritis: Results From a Prospective Multicenter French Cohort

  2013cited by this paper
• Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

  2013cited by this paper
• Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis

  2013cited by this paper
• Increased Risk of Ischemic Heart Disease in Young Patients with Newly Diagnosed Ankylosing Spondylitis – A Population-Based Longitudinal Follow-Up Study

  2013cited by this paper
• The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis.

  2013cited by this paper
• Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes.

  2013cited by this paper
• Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study

  2013cited by this paper
• Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis.

  2013cited by this paper
• Sociodemographic factors associated with cervical cancer screening coverage and follow-up of high grade abnormal results in a population-based cohort.

  2013cited by this paper
• Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis.

  2012cited by this paper
• Assessment of Preclinical Atherosclerosis in Patients with Ankylosing Spondylitis

  2012cited by this paper
• No increased rate of acute myocardial infarction or stroke among patients with ankylosing spondylitis-a retrospective cohort study using routine data.

  2012cited by this paper
• The prevalence of HLA-B27 in the US: data from the US National Health and Nutrition Examination Survey, 2009.

  2012cited by this paper
• Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China.

  2011cited by this paper
• Increased mortality in ankylosing spondylitis is related to disease activity

  2011cited by this paper
• Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study.

  2011cited by this paper
• Assessment of Subclinical Vascular Disease Associated with Ankylosing Spondylitis

  2011cited by this paper
• Atherosclerosis and endothelial dysfunction in patients with ankylosing spondylitis

  2010cited by this paper
• Signs of Accelerated Preclinical Atherosclerosis in Patients with Ankylosing Spondylitis

  2010cited by this paper
• The relationship between disease-related characteristics and conduction disturbances in ankylosing spondylitis

  2010cited by this paper
• Surname lists to identify South Asian and Chinese ethnicity from secondary data in Ontario, Canada: a validation study

  2010cited by this paper
• Pulmonary manifestations of ankylosing spondylitis.

  2010cited by this paper
• Overadjustment Bias and Unnecessary Adjustment in Epidemiologic Studies

  2009cited by this paper
• High prevalence of metabolic syndrome and cardiovascular risk factors in men with ankylosing spondylitis on anti-TNFalpha treatment: correlation with disease activity.

  2009cited by this paper
• Mortality in rheumatoid arthritis and ankylosing spondylitis.

  2009cited by this paper
• Ankylosing spondylitis: a risk factor for myocardial infarction?

  2009cited by this paper
• Mortality in ankylosing spondylitis.

  2008cited by this paper
• Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease.

  2008cited by this paper
• [Ischemic heart disease prevalence estimated using a standard algorithm based on electronic health data in various areas of Italy].

  2008cited by this paper
• Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor α blockade

  2008cited by this paper
• Spondyloarthritis: a strong predictor of early coronary artery bypass grafting

  2008cited by this paper
• Cardiovascular disease in patients with spondyloarthropathies.

  2008cited by this paper
• Accuracy of the diagnoses of spondylarthritides in veterans affairs medical center databases.

  2007cited by this paper
• Accuracy of administrative databases in identifying patients with hypertension

  2007cited by this paper
• Enhancing the effectiveness of health care for Ontarians through research Canadian Institute for Health Information Discharge Abstract Database : A Validation Study

  2006cited by this paper
• Impaired endothelial function in patients with ankylosing spondylitis.

  2006cited by this paper
• Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding

  2005cited by this paper
• Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease

  2004cited by this paper
• Ankylosing spondylitis--cardiac manifestations.

  2002cited by this paper
• Coronary disease surveillance in Olmsted County objectives and methodology.

  2002cited by this paper
• Survival of unselected stroke patients in a stroke unit compared with conventional care.

  2002cited by this paper
• Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis.

  2002cited by this paper
• Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm.

  2002cited by this paper
• Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis

  1998cited by this paper
• Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.

  1998cited by this paper
• Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link?

  1997cited by this paper
• Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis.

  1993cited by this paper
• Survival among patients with ankylosing spondylitis: a life-table analysis.

  1981cited by this paper
• Ankylosing spondylitis: survival in men with and without radiotherapy.

  1980cited by this paper
• Ankylosing spondylitis: survival in men with and without radiotherapy.

  1980cited by this paper
• Mortality among patients with ankylosing spondylitis not given X-ray therapy.

  1977cited by this paper
• Mortality in ankylosing spondylitis.

  1977cited by this paper

• Response to the correspondence by Wendling et al on 'ASAS consensus-based expert definition of difficult-to-manage, including treatment-refractory, axial spondyloarthritis'.

  2025cites this paper
• Risk of Heart Failure in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Study

  2025cites this paper
• Residual Traditional Risk in Non-Traditional Atherosclerotic Diseases

  2025cites this paper
• Comprehensive Economic Analysis of Healthcare Costs in Ankylosing Spondylitis: Treatment Strategies and Socioeconomic Implications

  2025cites this paper
• Cardiovascular risk in axial spondyloarthritis: the interplay of inflammation, traditional risk factors, and management strategies

  2025influential citation
• Choosing treatment and targeted therapy in axial Spondyloarthritis.

  2025cites this paper
• The impact of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: 10-year results from an inception cohort.

  2025cites this paper
• Fast, Present and Future of the Concept of Spondyloarthritis

  2025cites this paper
• Sex differences in biomarkers and biologic mechanisms in psoriatic diseases and spondyloarthritis.

  2025cites this paper
• The Effects of Disease-Modifying Antirheumatic Drugs on Cardiovascular Risk in Inflammatory Joint Diseases: Current Evidence and Uncertainties

  2025cites this paper
• Prevalence and risk factors of renal involvement in seronegative spondyloarthropathies: a systematic review

  2025cites this paper
• Does ankylosing spondylitis exert a bidirectional influence on hypertension? A two-sample Mendelian randomization study

  2025influential citation
• The Role of GLP-1 Receptor Agonists in Rheumatic Diseases: Cardioprotective Potentials, Anti-Inflammatory Effects, and Future Emerging Therapeutic Applications

  2025cites this paper
• Evaluating Outcomes in Patients With Ankylosing Spondylitis Seeking Acute Care By Utilizing Elixhauser Comorbidity Index: An Analysis of Cerner Health Facts Database From 2000 to 2017.

  2025cites this paper
• Risk of cardiovascular diseases and gastrointestinal bleeding is comparable between celecoxib and non-selective non-steroidal anti-inflammatory drugs in patients with ankylosing spondylitis: a nationwide retrospective cohort study

  2025cites this paper
• Does Sestrin-1 Mitigate Cardiovascular Risks in Radiographic Axial Spondyloarthritis?

  2025cites this paper
• Decoding the inflammatory-osteogenic axis in ankylosing spondylitis: mechanisms, dysregulation, and emerging therapeutic interventions

  2025cites this paper
• The association of TNF inhibitor use with incident cardiovascular events in radiographic axial spondyloarthritis.

  2024cites this paper
• HIF-1α and MIF enhance neutrophil-driven type 3 immunity and chondrogenesis in a murine spondyloarthritis model

  2024cites this paper
• Mortality and major adverse cardiovascular events after glucagon-like peptide-1 receptor agonist initiation in patients with immune-mediated inflammatory diseases and type 2 diabetes: A population-based study

  2024cites this paper
• Diabetes in axial spondyloarthritis: a systematic review and meta-analysis of observational studies

  2024cites this paper
• HLA-B27 and the role of specific T cell receptors in the pathogenesis of spondyloarthritis

  2024cites this paper
• Treatment strategies for Spondyloarthritis: Implementation of precision medicine - Or "one size fits all" concept?

  2024cites this paper
• The history of ankylosing spondylitis/axial spondyloarthritis - what is the driving force of new knowledge?

  2024cites this paper
• Occupational therapy assessments and interventions for patients with ankylosing spondylitis: a scoping review protocol.

  2024cites this paper
• A meta‐analysis of left ventricular dysfunction in ankylosing spondylitis

  2024cites this paper
• Exploring the Link Between Genetic Predictors of Cardiovascular Disease and Psoriasis

  2024cites this paper
• Diagnostik und Klassifikation der axialen Spondyloarthritis (axSpA) – der aktuelle Stand

  2024cites this paper
• Risk of cardiovascular disease decreases over time in psoriatic arthritis but not in spondylarthritis: meta-analysis of longitudinal studies.

  2024cites this paper
• Risk of cardiovascular disease associated with long-term use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis.

  2024cites this paper
• Total Hip Arthroplasty in Ankylosing Spondylitis: A Case Report of Ankylosed Hip

  2024cites this paper
• Association of ankylosing spondylitis with cardiovascular disease: a bidirectional two-sample mendelian randomization study

  2024cites this paper
• Axial spondyloarthritis—current aspects

  2024cites this paper
• Incidence rate of chronic kidney disease and its association with long‐term nonsteroidal anti‐inflammatory drug use in ankylosing spondylitis: A nationwide population‐based study

  2024influential citation
• An update on the management of axial spondyloarthritis for sports medicine professionals

  2024cites this paper
• Anti-OJ Antibody-positive Antisynthetase Myopathy Diagnosed after Pulmonary Embolization

  2024cites this paper
• Association between syndecan-4 and subclinical atherosclerosis in ankylosing spondylitis

  2024cites this paper
• Heart Rate Variability in Patients of Ankylosing Spondylitis: A Systematic Review and Meta-Analysis

  2024cites this paper
• Adhesion molecules and atherosclerosis in ankylosing spondylitis: implications for cardiovascular risk

  2024cites this paper
• Early-stage hypertension defined by the 2017 ACC/AHA blood pressure guideline carries excessive cardiovascular risk in axial spondyloarthritis patients

  2024cites this paper
• Obesity Represents a Persisting Health Issue in Axial Spondyloarthritis, Particularly Affecting Socially Disadvantaged Patients

  2023cites this paper
• The association between comorbidities and disease activity in spondyloarthritis - A narrative review.

  2023cites this paper
• Dysfunctional high-density lipoprotein in chronic inflammatory rheumatic diseases

  2023cites this paper
• Impact of NSAIDs on 8-year cumulative incidence of major cardiovascular events in patients with ankylosing spondylitis: a nationwide study.

  2023cites this paper
• Is There a Relationship between P Wave Dispersion and Aortic Elasticity Parameters in Ankylosing Spondylitis?

  2023influential citation
• Sex differences in cardiovascular and disease-related features in axial spondyloarthritis. A multicenter study of 912 patients.

  2023cites this paper
• Current aspects for the treatment of axial spondyloarthritis

  2023cites this paper
• Myocardial Involvement in Systemic Autoimmune Rheumatic Diseases.

  2023cites this paper
• Cardiovascular risk in axial spondyloarthritis—a systematic review

  2023cites this paper
• Inflammation is associated with incident hypertension in patients with axial spondyloarthritis: A longitudinal cohort study

  2023cites this paper
• Umgang mit NSAR bei der Behandlung der axialen Spondyloarthritis

  2023cites this paper
• Pakistani Ankylosing Spondylitis Cohort with modifiable cardiovascular risk factors (PAS-CVD) study

  2023cites this paper
• Mortality and Ankylosing Spondylitis in the US population: leading causes and associated factors

  2023cites this paper
• Cardiovascular disease in spondyloarthritis: a narrative review of risk factors and the effect of treatments

  2023cites this paper
• Safety and efficacy of pharmacological treatments for axial spondyloarthritis

  2023cites this paper
• Uveitis as a Risk Factor for Developing Acute Myocardial Infarction in Ankylosing Spondylitis: A National Population-Based Longitudinal Cohort Study

  2022cites this paper
• Cardiovascular Risks and Risk Stratification in Inflammatory Joint Diseases: A Cross-Sectional Study

  2022cites this paper
• Untargeted Lipidomics Reveals Characteristic Biomarkers in Patients with Ankylosing Spondylitis Disease

  2022cites this paper
• Treatment of axial spondyloarthritis: an update

  2022cites this paper
• Benefits of tumor necrosis factor inhibitors for cardiovascular disease in ankylosing spondylitis.

  2022cites this paper
• High inflammatory burden predicts cardiovascular events in patients with axial spondyloarthritis: a long-term follow-up study

  2022cites this paper
• Cardiac rhythm and conduction disturbances in patients with ankylosing spondylitis

  2022cites this paper
• Functional significance of the rare rs35667974 IFIH1 gene polymorphism, associated with multiple autoimmune diseases, using a structural biological approach

  2022cites this paper
• Association of blood pressure and hypertension with radiographic damage among the patients with ankyloing spondylitis

  2022cites this paper
• Nonsteroidal anti-inflammatory drugs and cardiovascular disease risk in spondyloarthritis-spectrum diseases

  2022cites this paper
• Effects of immune-mediated inflammatory diseases on cardiovascular diseases in patients with type 2 diabetes: a nationwide population-based study

  2022cites this paper
• Uveitis increases the risk of stroke among patients with ankylosing spondylitis: A nationwide population-based longitudinal study

  2022cites this paper
• Deep Insight into the Role of MIF in Spondyloarthritis

  2022cites this paper
• Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patients.

  2022cites this paper
• Cardiovascular Morbidity in Ankylosing Spondylitis: A Focus on Inflammatory Cardiac Disease

  2022influential citation
• Mortality Rates in Patients With Ankylosing Spondylitis With and Without Extraarticular Manifestations and Comorbidities: A Retrospective Cohort Study

  2022cites this paper
• Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 and Nov 22, 2021, in Ontario, Canada: a population-based analysis

  2022cites this paper
• Clinical Features and Drug Retention of TNF Inhibitors in Older Patients with Ankylosing Spondylitis: Results from the KOBIO Registry

  2022cites this paper
• All-cause and cause-specific mortality in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: a nationwide registry study

  2022cites this paper
• Effect of tumor necrosis factor inhibitors on risk of cardiovascular disease in patients with axial spondyloarthritis

  2022cites this paper
• A Statewide Study of Cardiovascular Outcomes in Patients with Ankylosing Spondylitis

  2022cites this paper
• COVID-19 Vaccination Uptake Among Individuals With Immune-mediated Inflammatory Diseases in Ontario, Canada, Between December 2020 and October 2021: A Population-based Analysis

  2022cites this paper
• The Effect of Ketogenic Diet on Inflammatory Arthritis and Cardiovascular Health in Rheumatic Conditions: A Mini Review

  2021cites this paper
• The Association of Tumor Necrosis Factor Inhibitor Use With Incident Hypertension in Ankylosing Spondylitis: Data From the PSOAS Cohort

  2021cites this paper
• Axial Spondyloarthritis: Clinical Characteristics, Epidemiology, and General Approaches to Management

  2021cites this paper
• All‐Cause and Cause‐Specific Mortality in Psoriatic Arthritis and Ankylosing Spondylitis: A Systematic Review and Meta‐Analysis

  2021influential citation
• Brazilian recommendations for the use of nonsteroidal anti-inflammatory drugs in patients with axial spondyloarthritis

  2021cites this paper
• Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients.

  2021cites this paper
• Relationship Between Body Mass Index, Disease Activity, and Exercise in Ankylosing Spondylitis

  2021cites this paper
• Carotid Artery Pathology in Inflammatory Diseases.

  2021cites this paper
• The Risk of Cardiovascular Diseases in Axial Spondyloarthritis. Current Insights

  2021cites this paper
• Seronegative Spondyloarthropathies

  2021cites this paper
• The Prevalence of Cardiac Diseases in a Contemporary Large Cohort of Dutch Elderly Ankylosing Spondylitis Patients—The CARDAS Study

  2021cites this paper
• The Trend of Targeted Therapies in Chinese Patients With Ankylosing Spondylitis: Results From a Real-Life Survey

  2021cites this paper
• The Association Between TNF Inhibitor Therapy Availability and Hospital Admission Rates for Patients with Ankylosing Spondylitis. A Longitudinal Population-Based Study

  2021cites this paper
• Motivators, Barriers, and Opportunity for E‐Health to Encourage Physical Activity in Axial Spondyloarthritis: A Qualitative Descriptive Study

  2021cites this paper
• Inflammatory Joint Diseases and Risk of Cardiovascular Disease in Modern Rheumatology

  2021cites this paper
• Treat-to-target in axial spondyloarthritis — what about physical function and activity?

  2021cites this paper
• Relation of therapies for ankylosing spondylitis and psoriatic arthritis to risk of myocardial infarction: a nested case control study

  2021cites this paper
• Post-transplant manifestation of ankylosing spondylitis: a case report and review of literature

  2021cites this paper
• Risk of Venous Thromboembolism in Ankylosing Spondylitis and Rheumatoid Arthritis: Genetic Aspects

  2021cites this paper
• [Algorithms to identify chronic inflammatory rheumatism and psoriasis in medico-administrative databases: A review of the literature].

  2021cites this paper
• Association of C-reactive protein and non-steroidal anti-inflammatory drugs with cardiovascular events in patients with psoriatic arthritis: a time-dependent Cox regression analysis

  2021cites this paper
• Effects of a 6-month exercise programme on disease activity, physical and functional parameters in patients with ankylosing spondylitis: Randomised controlled trial

  2021cites this paper
• Determination of serum methylarginine levels by tandem mass spectrometric method in patients with ankylosing spondylitis

  2021cites this paper